send to a friend by email
2023-11-26
According to the financial statements of Birzeit Pharmaceuticals Company BPC for the first nine months of 2023, Net profit after tax of the period reached 4,813,152 USD Compared with Net profit after tax 7,000,416 USD for 2022, a net decrease in profit of 31.24%.Total assets of the company reached 124,532,416 USD compared with total assets of 123,003,262 USD at the end of year 2022, a net increase of 1.24%.Total liabilities of the company reached 17,104,240 USD compared with total liabilities of 19,489,454 USD at the end of year 2022, a net decrease of 12.23%. Net ownership equity of the company reached 107,428,176 USD (Including Non-Controlling Interests of 682,700 USD) compared with total owner equity of 103,513,808 USD (Including Non-Controlling Interests of 923,623 USD) at the end of year 2022, a net increase of 3.78%.
|
|